- Report
- January 2022
- 60 Pages
Global
From €3797EUR$3,950USD£3,256GBP
- Report
- July 2022
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- July 2022
- 112 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- August 2022
United States
From €1865EUR$1,940USD£1,599GBP
- Report
- August 2022
Global
From €1144EUR$1,190USD£981GBP
- Report
- August 2021
Europe
From €3287EUR$3,420USD£2,819GBP
- Report
- August 2021
Global
From €3835EUR$3,990USD£3,289GBP
- Report
- February 2021
Global
From €2845EUR$2,960USD£2,440GBP
- Report
- August 2021
- 41 Pages
Global
From €3840EUR$3,995USD£3,293GBP
- Report
- August 2021
- 122 Pages
Global
From €10568EUR$10,995USD£9,062GBP
- Clinical Trials
- December 2021
- 643 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- September 2019
- 75 Pages
Global
From €3124EUR$3,250USD£2,679GBP
- Report
- September 2018
- 336 Pages
Global
From €21145EUR$22,000USD£18,133GBP
- Report
- October 2023
- 94 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- July 2021
- 115 Pages
Global
From €3200EUR$3,566USD£2,840GBP
- Report
- July 2022
- 518 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Drug Pipelines
- October 2020
- 550 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- November 2019
- 187 Pages
Global
From €5161EUR$5,370USD£4,426GBP
- Report
- April 2023
- 160 Pages
Global
From €5766EUR$5,999USD£4,945GBP
The Cystic Fibrosis Drug market is a subset of the larger Respiratory Drug market. It is composed of treatments and therapies designed to address the symptoms of cystic fibrosis, a genetic disorder that affects the lungs and digestive system. These drugs are used to reduce the amount of mucus in the lungs, improve breathing, and reduce the risk of infection. They may also be used to treat other symptoms, such as malnutrition, dehydration, and vitamin deficiencies.
The Cystic Fibrosis Drug market is highly competitive, with many companies developing and marketing treatments. Some of the major players in the market include Vertex Pharmaceuticals, Gilead Sciences, Novartis, and GlaxoSmithKline. Other companies, such as AbbVie, Merck, and Pfizer, are also active in the market. Show Less Read more